Related Experiment Videos

Daily administration of granulocyte colony stimulating factor using a subcutaneous butterfly

V Pegoli¹, D Kotasek

¹Department of Haematology/Oncology, Queen Elizabeth Hospital, Woodville, Australia.

International Journal of Nursing Practice

|June 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Early and late changes in markers of aortic stiffness with breast cancer therapy.

Internal medicine journal·2014

A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.

British journal of cancer·2009

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.

British journal of cancer·2007

See all related articles